Aggressive treatment for low-risk stage 4 non-small cell lung cancer (NSCLC) results in a 5-year overall survival rate of 47.8%.
Mice with melanoma that exercised during chemotherapy had increased tumor shrinkage.
ASTRO recommendations indicate treatment options that should be discussed before being prescribed.
Chokeberry extract enhances cytotoxicity of gemcitabine on a single cancer cell line.
Boehringer Ingelheim and CureVac have begun trials for a vaccine in early clinical development for the treatment of patients with lung cancer.
Less invasive method may increase screening rates for cervical cancer, researchers say.
High rates of preserved sexual function with combination beam plus brachytherapy.
Mammograms for those aged 69 to 75 could result in overtreatment, researchers caution.
Researchers have identified 23 genes that are associated with an increased risk for developing prostate cancer.
But aging population and increasing obesity threaten progress, notes American Association for Cancer Research.
Health sector prices explain much of difference between U.S. and other high-spending countries.
Millions signing up for Medicaid to comply with federal health care law.
Almost 80% of doctors in the United States have switched from paper to electronic health records.
Most physicians believe that doctors order too many medical tests, yet half admit to doing so themselves in response to a patient who insists, a new survey shows.
Several modifiable risk factors can cut chronic disease deaths over the next 15 years.
Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.
A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.
The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.
ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.
Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|